Protagenic Therapeutics, Inc.
NNASDAQ:PTIXWShare Statistics
As of December 31, 2025, Protagenic Therapeutics, Inc. has 1.93M shares outstanding.
| Shares Outstanding | 1.93M |
Financial Position
As of December 31, 2025, Protagenic Therapeutics, Inc. maintains a current ratio of 0.34, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -167.02, indicating conservative leverage, while an interest coverage ratio of -19.67 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.34 |
| Quick Ratio | 0.33 |
| Debt / Equity | -167.02 |
| Debt / EBITDA | -0.85 |
| Interest Coverage | -19.67 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -161.46, reflecting losses generated across the asset base. Return on capital employed (ROCE) is 22.78, useful for judging operating efficiency across full business cycles.
| Return on Assets (ROA) | -161.46 |
| Return on Capital Employed (ROCE) | 22.78 |
Scores
As of December 31, 2025, Protagenic Therapeutics, Inc. has an Altman Z-Score of -14.41, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -14.41 |